Multiple Myeloma Progression
13 clinical trials · Condition
◉ Watch Multiple Myeloma Progression
| Record | Firm | Date |
|---|---|---|
| Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma (NCT03428373) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2019-01-17 |
| Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R MM (NCT03706547) | Peng Liu | 2018-10-30 |
| Tinostamustine Conditioning and Autologous Stem Cell (NCT03687125) | Mundipharma-EDO GmbH | 2018-10-15 |
| Pomalidomide/Cyclophosphamide/Dexamethasone in Relapse Refractory Myeloma: Safety Profile in Mexicans (NCT03601624) | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | 2018-09-01 |
| CAR-T Re-treatment for Refractory/Relapsed Multiple Myeloma (NCT03672253) | Second Affiliated Hospital of Xi'an Jiaotong University | 2018-07-26 |
Track Multiple Myeloma Progression automatically
Every clearance here is in the API, with alerts when new ones post.